Filtered By:
Management: Funding
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 8950 results found since Jan 2013.
Greater executive dysfunction in patients post-COVID-19 compared to those not infected
Brain Behav Immun. 2023 Aug 14:S0889-1591(23)00237-4. doi: 10.1016/j.bbi.2023.08.014. Online ahead of print.ABSTRACTBACKGROUND: A number of patients post-coronavirus disease-19 (COVID-19) report cognitive impairment (CI), even months after acute infection. We aimed to assess if COVID-19 is associated with increased incidence of CI in comparison to controls.METHODS: We analyzed data from the Mount Sinai Health System Post-COVID-19 Registry in New York City, a prospective cohort of patients post-COVID-19 ≥18 years of age and non-infected controls. CI was defined by scores ≥1.0 standard deviation below population norms, a...
Source: Brain, Behavior, and Immunity - August 16, 2023 Category: Neurology Authors: Jacqueline H Becker Jenny J Lin Akosua Twumasi Ruchir Goswami Fernando Carnavali Kimberly Stone Monica Rivera-Mindt Minal S Kale Georges Naasan Joanne R Festa Juan P Wisnivesky Source Type: research
Industry-Sponsored Research Funding to Rheumatologists in the United States Between 2014 and 2022
J Rheumatol. 2023 Aug 15:jrheum.2023-0417. doi: 10.3899/jrheum.2023-0417. Online ahead of print.ABSTRACTRheumatologists are responsible for conducting research on, managing, and treating major autoimmune diseases (AIDs) such as rheumatoid arthritis (RA), systemic lupus erythematosus, and psoriasis. AIDs afflict up to 23.5 million people in the United States.PMID:37582555 | DOI:10.3899/jrheum.2023-0417
Source: J Rheumatol - August 15, 2023 Category: Rheumatology Authors: Anju Murayama Source Type: research
